News
ABT
106.86
-0.03%
-0.03
3 Best Healthcare Stocks to Buy in April 2024, According to Analysts
TipRanks · 2h ago
Dexcom's profit beats estimates on strong glucose monitor demand
Dexcom's profit beats estimates on strong glucose monitor demand. Company's total revenue rose 24% to $921 million in the first quarter. But company's annual sales forecast was largely below estimates. The company's shares slid 7% after the bell. Company and rival Abbott dominate the market for continuous glucose monitors.
Reuters · 13h ago
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength
Edwards Lifesciences first-quarter profit beats estimates on heart devices strength. Company expects annual sales growth to be at the higher end of its 8% to 10% forecast. Sales of Edwards' artificial heart valves rose 6% to $1 billion in the first quarter.
Reuters · 13h ago
Should You Pick Intuitive Surgical Stock At $370?
NASDAQ · 1d ago
Not A Millionaire? No Problem! Here's A 10-Stock Portfolio To Retire Comfortably
The retirement crisis may not be as bad as it seems, with most retirees doing fine with less savings than expected. The expected amount to retire comfortably in the United States is now north of $1.4 million. The average retirement savings for U.S. Adults is only $88,400. A low-risk portfolio consisting of dividend growth stocks can yield substantial returns in retirement.
Seeking Alpha · 3d ago
Should You Pick Abbott Stock At $105 After An Upbeat Q1?
NASDAQ · 3d ago
3 Best Stocks to Buy Now, 4/23/2024, According to Top Analysts 
TipRanks · 3d ago
Abbott Labs Is Maintained at Overweight by Barclays
Dow Jones · 3d ago
Abbott Labs Price Target Cut to $140.00/Share From $141.00 by Barclays
Dow Jones · 3d ago
Barclays Maintains Overweight on Abbott Laboratories, Lowers Price Target to $140
Benzinga · 3d ago
ABBOTT LABORATORIES <ABT.N>: BARCLAYS CUTS TARGET PRICE TO $140 FROM $141
Reuters · 4d ago
Weekly Report: what happened at ABT last week (0415-0419)?
Weekly Report · 4d ago
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Eli Lilly & Co (LLY)
TipRanks · 4d ago
Analysts Conflicted on These Healthcare Names: Terns Pharmaceuticals (TERN), Abbott Labs (ABT) and Arcutis Biotherapeutics (ARQT)
TipRanks · 4d ago
Why I Believe Abbott Is Much Better Positioned In Today's Rising Inflation Scenario
Abbott Laboratories is a healthcare company with pricing power and a strong dividend growth track record. Inflation concerns are rising in the United States, particularly in healthcare. The company just released its 1Q24 earnings. Abbott is one of the healthcare companies that benefitted tremendously from the pandemic. Despite recent challenges, Abbott's core business remains robust.
Seeking Alpha · 4d ago
THQ: Collecting A High Yield From Increased Medical Spending
Abrdn Healthcare Opportunities Fund (THQ) offers a high dividend yield of 11.3% and exposure to diverse subsectors of the healthcare industry. The healthcare sector has lagged behind the S&P500 for the past year. THQ trades at an attractive discount to its NAV. The fund is diversified across 11 different sub sectors of healthcare.
Seeking Alpha · 5d ago
IGA: This 12% Yielding Global Equity CEF Now Pays Monthly
Seeking Alpha · 5d ago
20 Years To $300k? Building A $10,000 Dividend Portfolio From Scratch
Seeking Alpha · 6d ago
At least 70% of the S&P 500 names that reported results this week topped estimates - Earnings Scorecard
Seeking Alpha · 6d ago
Analysts Offer Insights on Healthcare Companies: Abbott Labs (ABT) and Elevance Health (ELV)
TipRanks · 04/19 01:30
More
Webull provides a variety of real-time ABT stock news. You can receive the latest news about Abbott Labs through multiple platforms. This information may help you make smarter investment decisions.
About ABT
Abbott Laboratories is a global healthcare company. The Company is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The Company operates through four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. The Diagnostic Products segment is engaged in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Nutritional Products segment is involved in the worldwide sales of a broad line of adult and pediatric nutritional products. The Medical Devices segment includes the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation, and diabetes care products.